case 2: evolution of molecular testing in myeloma
Published 5 years ago • 41 plays • Length 2:43Download video MP4
Download video MP3
Similar videos
-
6:50
case 2: molecular risk stratification in myeloma
-
3:58
case 1: molecular testing in myeloma
-
4:41
case 2: the role of maintenance therapy in myeloma
-
4:59
case 3: molecular testing in relapsed myeloma
-
3:59
case 2: determining risk in myeloma
-
2:24
the importance of molecular testing in multiple myeloma and how this may impact future treatment
-
5:50
case 2: mrd negativity in high-risk myeloma
-
1:00:19
the molecular twin platform: a multi-omic approach for predicting accurate clinical outcomes
-
3:07
case 4: molecular testing and car t-cell therapy in myeloma
-
3:01
diagnosis of stage 2 multiple myeloma
-
5:45
evolution of diagnostic and response criteria in multiple myeloma
-
1:03
dr. dimopoulos on evolution of selinexor in multiple myeloma
-
1:22
an all-molecular diagnostic approach for myeloma
-
1:23
exploring the use of liquid biopsies in smoldering multiple myeloma
-
4:06
case 4: car t-cell therapy in myeloma
-
4:23
case study 1: a diagnosis of stage ii multiple myeloma
-
1:00
understanding multiple myeloma heterogeneity by utilizing ngs
-
11:27
can your myeloma genetics change over time? what is clonal evolution (clonal tides)?
-
0:36
promise of gprc5d-targeted car-t therapies in multiple myeloma